P2RX5
P2X purinoceptor 5
Also known as: LRH-1, P2RX5_HUMAN, P2X5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q93086
- Gene
- P2RX5
- Ensembl
- ENSG00000083454
- Chromosome
- 17
- Canonical length
- 444 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream gene, TAX1BP3 (Tax1 binding protein 3). [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
444 residues, UniProt reviewed canonical sequence.
>Q93086|P2RX5
1 MGQAGCKGLC LSLFDYKTEK YVIAKNKKVG LLYRLLQASI LAYLVVWVFL IKKGYQDVDT
61 SLQSAVITKV KGVAFTNTSD LGQRIWDVAD YVIPAQGENV FFVVTNLIVT PNQRQNVCAE
121 NEGIPDGACS KDSDCHAGEA VTAGNGVKTG RCLRRENLAR GTCEIFAWCP LETSSRPEEP
181 FLKEAEDFTI FIKNHIRFPK FNFSKSNVMD VKDRSFLKSC HFGPKNHYCP IFRLGSVIRW
241 AGSDFQDIAL EGGVIGINIE WNCDLDKAAS ECHPHYSFSR LDNKLSKSVS SGYNFRFARY
301 YRDAAGVEFR TLMKAYGIRF DVMVNGKAGK FSIIPTIINV GSGVALMGAG AFFCDLVLIY
361 LIKKREFYRD KKYEEVRGLE DSSQEAEDEA SGLGLSEQLT SGPGLLGMPE QQELQEPPEA
421 KRGSSSQKGN GSVCPQLLEP HRSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against P2RX5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 74 nTPM
- spleen: 53 nTPM
- tonsil: 51 nTPM
- appendix: 30 nTPM
- small intestine: 24 nTPM
- skeletal muscle: 17 nTPM
Single-cell type
- b-cells: 1.7 nCPM
- thymic myoid cells: 1.4 nCPM
- megakaryocyte-erythroid progenitors: 1.3 nCPM
- plasma cells: 1.2 nCPM
- thymocytes: 0.8 nCPM
- innate lymphoid cells: 0.2 nCPM
Immune cell
- naive B-cell: 86 nTPM
- memory B-cell: 77 nTPM
- total PBMC: 4.5 nTPM
- MAIT T-cell: 4.3 nTPM
- gdT-cell: 3.1 nTPM
- memory CD4 T-cell: 2.8 nTPM
Brain region
- cerebral cortex: 10 nTPM
- basal ganglia: 8.4 nTPM
- white matter: 6.7 nTPM
- amygdala: 6.3 nTPM
- hypothalamus: 6 nTPM
- hippocampal formation: 5.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.74
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- chloride transport
- nervous system development
- osteoclast maturation
- positive regulation of calcium ion import across plasma membrane
- positive regulation of calcium ion transport into cytosol
- positive regulation of calcium-mediated signaling
- regulation of skeletal muscle tissue regeneration
- response to ATP
- response to calcium ion
- response to pH
- response to zinc ion
- signal transduction
Molecular functions
- ATP binding
- extracellularly ATP-gated monoatomic cation channel activity
- identical protein binding
- ligand-gated monoatomic anion channel activity
- monoatomic ion channel activity
- purinergic nucleotide receptor activity
- transmembrane signaling receptor activity
- voltage-gated monoatomic ion channel activity
- ATP-gated ion channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads P2RX5 as an antibody target. Whether an autoantibody or antibody against P2RX5 could matter depends on whether native P2RX5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
P2RX5 is annotated at the cell surface, where native P2RX5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label P2RX5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...